Age (years) | 63.7 (6.1) | 68.1 (4.8) | NS |
No. of women (%) | 5 (50%) | 6 (55%) | NS |
Height (m) | 1.7 (0.1) | 1.7 (0.1) | NS |
Weight (kg) | 70.4 (12.6) | 76.2 (13.1) | NS |
Duration of disease (years) | 10.4 (7.2) | – | – |
Fallers (⩽3 months) | 6 (60%) | 1 (9.1%)† | p = 0.07 |
Fear of falling | 6 (60%) | 1 (9.1%) | p = 0.07 |
Activities-specific Balance Confidence Scale (%) | 62 (19) | 89 (11) | p<0.01 |
Medication | | | |
Levodopa/carbidopa | 9 (90%) | – | |
Dopamine receptor agonist | 8 (80%) | – | |
Amantadine | 8 (80%) | – | |
Anticholinergic | 4 (40%) | – | |
Other | | – | |
Benzodiazepine | 4 (40%) | – | |
Clozapine | 4 (40%) | – | |
Cisapride | 1 (10%) | – | |
Omeprazole | 1 (10%) | 1 (9.1%) | |
Diuretics | 0 (0%) | 1 (9.1%) | |